Jazz Pharmaceuticals (JAZZ) PT Raised to $275 at TD Cowen
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $230.56 -2.38%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
TD Cowen analyst Joseph Thome, Ph.D raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $275.00 (from $220.00) while maintaining a Buy rating.
You May Also Be Interested In
- Adobe (ADBE) PT Lowered to $225 at UBS Amid Plans to Pivot to Freemium Model
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR18 at JPMorgan
- Bernstein SocGen Reiterates Market Perform Rating on Jazz Pharmaceuticals (JAZZ)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
